Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEACE: Labetalol vs Nifedipine for Postpartum Hypertension
NCT06915792Phase 4Recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Jun 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of labetalol, nifedipine GITS in hypertension (HTN), sponsored by University of California, Los Angeles. Started Jun 2025; status: recruiting.
02
Drugs
labetalolnifedipine GITS
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT06915792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06915792.